Table 4 Proportion missed, workload savings, and estimated time savings for the dual independent screening simulations
Systematic review name | Proportion missed, single reviewer, n (%) a | Dual independent screening, fully automated simulation | Dual independent screening, semi-automated simulation | ||||
|---|---|---|---|---|---|---|---|
Proportion missed, n (%) | Workload savings, n (%) | Time savings, hours (days) | Proportion missed, n (%) | Workload savings, n (%) | Time savings, hours (days) | ||
Biomarkers | 1 (2) | 0 (0) | 1612 (47) | 13 (2) | 6 (13) | 1109 (32) | 9 (1) |
Brain injury | 2 (5) | 0 (0) | 6062 (48) | 51 (6) | 0 (0) | 3936 (31) | 33 (4) |
Activity and pregnancy | 11 (11) | 1 (1) | 2728 (47) | 23 (3) | 1 (1) | 2409 (41) | 20 (3) |
Concussion | 0 (0) | 0 (0) | 1239 (43) | 10 (1) | 0 (0) | 601 (21) | 5 (< 1) |
Antipsychotics | 4 (3) | 2 (2) | 11,956 (49) | 100 (12) | 3 (2) | 9839 (40) | 82 (10) |
Digital technologies for pain | 0 (0) | 0 (0) | 2462 (46) | 21 (3) | 0 (0) | 2141 (40) | 18 (2) |
Treatments for bronchiolitis | 10 (7) | 1 (1) | 5661 (48) | 47 (6) | 1 (1) | 5005 (43) | 42 (5) |
VBAC | 5 (24) | 3 (14) | 4892 (48) | 41 (5) | 3 (14) | 3402 (33) | 28 (4) |
Visual acuity | 0 (0) | 0 (0) | 11,029 (49) | 92 (11) | 0 (0) | 7390 (33) | 62 (8) |
Experience of bronchiolitis | 12 (43) | 1 (1) | 451 (35) | 4 (< 1) | 1 (1) | 340 (26) | 3 (< 1) |
Experiences of UTIs | 0 (0) | 0 (0) | 1293 (43) | 11 (1) | 0 (0) | 447 (15) | 4 (< 1) |